Loading clinical trials...
Loading clinical trials...
Predictive Factors for Resection and Survival in Type A Borderline Resectable Pancreatic Ductal Adenocarcinoma Patients After Neoadjuvant Therapy: A Retrospective Cohort Study
Conditions
Interventions
Resection
No Resection
Start Date
September 1, 2022
Primary Completion Date
October 1, 2022
Completion Date
January 1, 2023
Last Updated
August 5, 2022
NCT07153289
NCT02310230
NCT02658214
NCT02456051
Lead Sponsor
BUSQUETS, JULI
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions